IP Library Granted Patent US 8,557,287
Granted Patent B2
US 8,557,287 · App. 10/913,656 · Granted Oct 15, 2013

Silicone gel composition and dispenser therefor

Inventor: Jeff S. Schleuning (Las Vegas, NV)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,557,287
App. No.
10/913,656
Granted
Oct 15, 2013
Kind
B2
Abstract

A therapeutic silicone composition and a delivery device operable for the self-administration of the therapeutic silicone composition to the skin. Silicone gel compositions are known in the art to promote wound healing and reduce scarring. The therapeutic silicone composition of the present invention contains a silicone gel formulated with inert thickening agents and/or carriers sufficient to provide a firm, semisolid silicone gel material that substantially retains its shape when extruded from a tube. When topically applied to hypertrophic tissue, the composition, which is applied as a light film to cover the tissue, is transparent and substantially dry, obviating the need for an occlusive dressing.

Claims (8)

1. A process of making a firm, semi-solid silicone composition comprising the steps of:

a. melting 7.85 wt. % of candelilla wax with 7.85 wt. % cera alba to form a molten mixture;

b. mixing 58.87 wt. % cetyl dimethicone copolyol with 24.53 wt. % polydimethylsilicone to form a silicone gel;

c. adding said silicone gel into said molten mixture with stirring;

d. adding 0.49 wt. % of Vitamin E, 0.39 wt. % of bisabolol, and 0.02 wt. % EDTA into said molten mixture with continued stirring; and

e. transferring said molten mixture in aliquots to a reservoir of a dispenser and allowing said molten mixture to cool to room temperature,

wherein said composition is firm at room temperature and substantially retains its shape when extruded from said dispenser.

2. A method for treating hypertrophic tissue of the skin comprising the topical application of a silicone gel composition made in accordance with the process of claim 1 directly to the hypertrophic tissue.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2022
From: SILVER OAK CAPITAL, L.L.C.
To: BIODERMIS LLC
Reel/Frame 062184/0682 →
CERTIFICATE OF CONVERSION AND FORMATION (NV LLC TO DE LLC) Recorded Nov 2, 2022
From: BIODERMIS LLC
To: BIODERMIS LLC
Reel/Frame 061874/0895 →
SECURITY INTEREST Recorded Aug 29, 2022
From: BIODERMIS LLC
To: ENTERPRISE BANK & TRUST
Reel/Frame 060931/0682 →
SECURITY INTEREST Recorded Jul 25, 2022
From: BIODERMIS LLC
To: MEDALLION CAPITAL, INC.
Reel/Frame 060607/0322 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 060406 FRAME: 0994. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jul 15, 2022
From: SCHLEUNING, JEFF S.
To: BIODERMIS LLC
Reel/Frame 060668/0784 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2022
From: SCHLEUNING, JEFF S.
To: BIODERMIS CORPORATION
Reel/Frame 060406/0994 →
SECURITY AGREEMENT Recorded May 11, 2006
From: INTELLECTUAL PROPERTY INTERNATIONAL, INC.
To: SILVER OAK CAPITAL, L.L.C.
Reel/Frame 017596/0673 →
Continuity (1)
Related Publication 20060029672A1 · Feb 9, 2006